Proprietary AI analyst is now available

Osang Healthcare Valuation Multiples

Discover Osang Healthcare's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Envoy Medical, Tobii, Anatolia Geneworks, iNtRON Biotechnology and more.

Osang Healthcare Overview

About Osang Healthcare

Osang Healthcare Co Ltd is engaged in medical device development. It develops diagnostic biosensors for blood glucose measurement, HbA1c and cholesterol , Immuno Diagnosis, Molecular Diagnosis, etc.


Founded

1996

HQ

South Korea

Employees

N/A

Financials (FY)

Revenue: $84M
EBITDA: $7M

EV

$57M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Osang Healthcare Financials

Osang Healthcare reported last fiscal year revenue of $84M and EBITDA of $7M.

In the same fiscal year, Osang Healthcare generated $37M in gross profit, $7M in EBITDA, and $2M in net income.


Osang Healthcare P&L

In the most recent fiscal year, Osang Healthcare reported revenue of $84M and EBITDA of $7M.

Osang Healthcare is profitable as of last fiscal year, with gross margin of 44%, EBITDA margin of 9%, and net margin of 2%.

See analyst estimates for Osang Healthcare
Last FY202320242025202620272028
Revenue$84M$231M$52M$84M
Gross Profit$37M$144M$17M$37M
Gross Margin44%62%32%44%
EBITDA$7M$103M($10M)$7M
EBITDA Margin9%45%(20%)9%
EBIT Margin2%40%(31%)2%
Net Profit$2M$76M($7M)$2M
Net Margin2%33%(14%)2%
Net Debt$15M---

Financial data powered by Morningstar, Inc.

Osang Healthcare Stock Performance

Osang Healthcare has current market cap of $50M, and enterprise value of $57M.

Market Cap Evolution


Osang Healthcare's stock price is $3.58.

Osang Healthcare share price decreased by 21.1% in the last 30 days.

Osang Healthcare has an EPS (earnings per share) of $0.14.

See more trading valuation data for Osang Healthcare
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$57M$50M-10.6%-21.1%--$0.14

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Osang Healthcare Valuation Multiples

Osang Healthcare trades at 0.7x EV/Revenue multiple, and 7.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Osang Healthcare

Osang Healthcare Financial Valuation Multiples

As of June 24, 2026, Osang Healthcare has market cap of $50M and EV of $57M.

Osang Healthcare has a P/E ratio of 24.7x.

Last FY202320242025202620272028
EV/Revenue0.7x0.2x1.1x0.7x
EV/EBITDA7.6x0.5x(5.5x)7.6x
EV/EBIT35.8x0.6x(3.5x)35.8x
EV/Gross Profit1.5x0.4x3.4x1.5x
P/E24.7x0.7x(6.8x)24.7x
EV/FCF(6.8x)0.7x(1.7x)(6.8x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Osang Healthcare Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Osang Healthcare Margins & Growth Rates

In the most recent fiscal year, Osang Healthcare reported gross margin of 44%, EBITDA margin of 9%, and net margin of 2%.

See estimated margins and future growth rates for Osang Healthcare

Osang Healthcare Margins

Last FY20242025202720282029
Gross Margin44%32%44%
EBITDA Margin9%(20%)9%
EBIT Margin2%(31%)2%
Net Margin2%(14%)2%
FCF Margin(10%)(64%)(10%)

Osang Healthcare Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(77%)60%
Gross Profit Growth(88%)123%
EBITDA Growth(110%)(172%)
EBIT Growth(117%)(110%)
Net Profit Growth(110%)(127%)
FCF Growth(144%)(75%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Osang Healthcare Operational KPIs

Access forward-looking KPIs for Osang Healthcare
Last FY202320242025202620272028
S&M Expenses to Revenue10%11%14%10%
G&A Expenses to Revenue4%1%6%4%
R&D Expenses to Revenue15%5%25%15%
Opex to Revenue43%22%62%43%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Osang Healthcare Competitors

Osang Healthcare competitors include Envoy Medical, Tobii, Anatolia Geneworks, iNtRON Biotechnology, OssDsign, Cyclopharm, Nortech Systems, Modulight, SMAIO and Myomo.

Most Osang Healthcare public comparables operate across Medical Devices, Diagnostics & Genomics, BioTech and DeepTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Envoy Medical106.6x116.1x(1.2x)-
Tobii1.1x1.2x3.1x4.1x
Anatolia Geneworks3.6x-(26.8x)-
iNtRON Biotechnology8.1x-(6.6x)-
OssDsign1.5x1.6x(7.3x)(6.7x)
Cyclopharm2.1x2.0x(4.4x)(4.2x)
Nortech Systems0.5x-28.4x-
Modulight5.4x5.1x(993.0x)65.1x

This data is available for Pro users. Sign up to see all Osang Healthcare competitors and their valuation data.

Start Free Trial

Investments by Osang Healthcare

Osang Healthcare has invested in 2 companies to date.

Latest investment by Osang Healthcare was on May 22nd 2024. Osang Healthcare invested in Allez Health in their $60M Series A round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Osang Healthcare

Allez Health
Kryptos Biotechnologies
Description
Allez Health is a San Diego-headquartered developer of wearable biosensors that analyze sweat for real-time monitoring of hydration status, electrolyte balance, lactate, and glucose levels. Their forearm patch device, AMP, connects to mobile apps and digital health platforms for athletes, military personnel, and clinical applications. The company partners with organizations like the U.S. Special Operations Command and integrates with Garmin wearables. Founded in 2016, Allez Health serves professional sports teams and expands into metabolic health tracking across North America and Europe.
Kryptos Biotechnologies is a Hayward-headquartered life sciences company founded in 2017. It develops single-cell spatial proteomics platforms analyzing protein expression in tissue samples at subcellular resolution. The Muse system images 50+ biomarkers simultaneously using mass cytometry, generating datasets for cancer diagnostics and drug discovery. Deployed in academic labs and pharma, it processes 1,000 cells per second with AI segmentation.
HQ CountryUnited StatesUnited States
HQ City
San Diego, CA
San Francisco, CA
Deal Date22 May 202428 Mar 2024
RoundSeries ASeries A
Raised$60M$10M
InvestorsOsang HealthcareOsang Healthcare
Valuationundisclosed$38M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Osang Healthcare investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Osang Healthcare

When was Osang Healthcare founded?Osang Healthcare was founded in 1996.
Where is Osang Healthcare headquartered?Osang Healthcare is headquartered in South Korea.
Is Osang Healthcare publicly listed?Yes, Osang Healthcare is a public company listed on Korea Exchange.
What is the stock symbol of Osang Healthcare?Osang Healthcare trades under 036220 ticker.
When did Osang Healthcare go public?Osang Healthcare went public in 2024.
Who are competitors of Osang Healthcare?Osang Healthcare main competitors include Envoy Medical, Tobii, Anatolia Geneworks, iNtRON Biotechnology, OssDsign, Cyclopharm, Nortech Systems, Modulight, SMAIO, Myomo.
What is the current market cap of Osang Healthcare?Osang Healthcare's current market cap is $50M.
What is the current revenue of Osang Healthcare?Osang Healthcare's last fiscal year revenue is $84M.
What is the current EV/Revenue multiple of Osang Healthcare?Current revenue multiple of Osang Healthcare is 0.7x.
Is Osang Healthcare profitable?No, Osang Healthcare is not profitable.
How many companies Osang Healthcare has acquired to date?Osang Healthcare hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Osang Healthcare has invested to date?As of June 2026, Osang Healthcare has invested in 2 companies.
What was the last Osang Healthcare investment?On 22nd May 2024 Osang Healthcare invested in Allez Health, participating in a $60M Series A round.
In what companies Osang Healthcare invested in?Osang Healthcare invested in Allez Health and Kryptos Biotechnologies.

See public comps similar to Osang Healthcare

Lists including Osang Healthcare

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial